Your session is about to expire
What is Gilotrif
Approved as Treatment by the FDA
Afatinib, otherwise called Gilotrif, is approved by the FDA for 5 uses such as Metastatic Non-Small Cell Lung Cancer and refractory, metastatic squamous cell Non-small cell lung cancer .Effectiveness
When to interrupt dosage
The measure of Gilotrif relies upon the diagnosed condition, including Exons, Non-Small Cell Lung Carcinoma and Malignant Neoplasms. The magnitude of dosage can be found in the table below, depending on the technique of delivery.Warnings
There are 20 known major drug interactions with Gilotrif.Gilotrif Novel Uses: Which Conditions Have a Clinical Trial Featuring Gilotrif?
Currently, 9 active studies are assessing the potential of Gilotrif for Exon-based Malignant Neoplasms and Non-Small Cell Lung Carcinoma.Gilotrif Reviews: What are patients saying about Gilotrif?
Patient Q&A Section about gilotrif
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.Is Gilotrif covered by Medicare?
"Does Medicare cover the cost of Gilotrif? Yes, 100% of Medicare plans cover this drug."
What is afatinib drug used for?
"Afatinib is used to treat patients with non-small cell lung cancer that has spread to other parts of the body and who have certain types of abnormal epidermal growth factor receptor genes. This is the first treatment that these patients have received for their cancer."
What is Gilotrif used for?
"GILOTRIF is a prescription medicine that is used to treat people with non-small cell lung cancer (NSCLC) that: has certain (non-resistant) abnormal epidermal growth factor receptor (EGFR) gene(s). Your healthcare provider will perform a test to make sure that GILOTRIF is right for you."
How do you take a Gilotrif?
"Make sure to take GILOTRIF at least an hour before or two hours after a meal, and try not to miss a dose. If you do, make sure it's more than 12 hours before your next planned dose."